Obesity Is Independently Associated With Increased Risk of Fecal Incontinence and Altered Rectal Sensitivity
- PMID: 39773574
- PMCID: PMC12234804
- DOI: 10.14309/ajg.0000000000003308
Obesity Is Independently Associated With Increased Risk of Fecal Incontinence and Altered Rectal Sensitivity
Abstract
Introduction: Hindgut symptoms are poorly understood complications of obesity. The impact of obesity on fecal incontinence (FI) and anorectal physiology remains unclear, with inconsistent results in prior studies. We aimed to evaluate the relationship between obesity and FI, and the physiological changes in anorectal function.
Methods: This was a retrospective cohort study of consecutive adults who underwent high-resolution anorectal manometry (HRAM) at a tertiary center for anorectal symptoms. Demographics, clinical history, surgical/obstetric history, medications, and HRAM findings were reviewed. Patients were classified as nonobese (body mass index [BMI] <25 kg/m 2 ), overweight (BMI 25-29.9 kg/m 2 ), class I obesity (30-34.9 kg/m 2 ), and class II + III obesity (>35 kg/m 2 ). The Fisher exact/Student t test for univariate analyses and logistic/general linear regression for multivariable analyses were performed.
Results: A total of 552 adults were included. The mean BMI was higher among patients with FI (27.5 vs 25.9 kg/m 2 , P = 0.013). Compared with the nonobese group, FI was more prevalent in class II + III obesity (31.7% vs 13.2%, P = 0.0024), but not class I obesity or overweight groups. On multivariable analysis controlling for potential confounders, class II + III obesity (adjusted odds ratio 2.89, 95% confidence interval 1.28-6.50, P = 0.02) remained an independent risk factor of FI. Among patients with FI, both BMI (β-coefficient 1.09, P = 0.016) and class II + III obesity (β-coefficient 18.9, P = 0.027) independently predicted increased first rectal sensation volume on HRAM on multivariable regression.
Discussion: Classes II + III obesity was an independent risk factor of FI. Among patients with FI, increasing BMI and class II + III obesity were associated with altered rectal sensitivity. Anorectal function testing should be considered to help guide management of FI among patients with obesity.
Copyright © 2025 by The American College of Gastroenterology.
Similar articles
-
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18. Am J Obstet Gynecol MFM. 2022. PMID: 35728780
-
Obesity is an independent risk factor for postoperative pulmonary embolism after anterior cervical discectomy and fusion.Spine J. 2025 Feb;25(2):299-305. doi: 10.1016/j.spinee.2024.09.028. Epub 2024 Sep 26. Spine J. 2025. PMID: 39341574
-
Obesity as an independent risk factor for COVID-19 severity and mortality.Cochrane Database Syst Rev. 2023 May 24;5(5):CD015201. doi: 10.1002/14651858.CD015201. Cochrane Database Syst Rev. 2023. PMID: 37222292 Free PMC article.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
References
-
- Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. Aug 30 2014;384(9945):766–81. doi: 10.1016/S0140-6736(14)60460-8 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources